OnADose
ASO Keyword Dashboard
Tracking 101 keywords for OnADose in Apple App Store
OnADose tracks 101 keywords (no keywords rank yet; 101 need traction). Key metrics: opportunity 49.8, difficulty 37.1.
Tracked keywords
101
0 ranked • 101 not ranking yet
Top 10 coverage
—
Best rank — • Latest leader —
Avg opportunity
49.8
Top keyword: range
Avg difficulty
37.1
Lower scores indicate easier wins
Opportunity leaders
- 70.5
range
Opportunity: 58.0 • Difficulty: 48.4 • Rank —
Competitors: 261
- 59.3
medical
Opportunity: 58.0 • Difficulty: 38.6 • Rank —
Competitors: 60
- 71.8
used
Opportunity: 58.0 • Difficulty: 52.9 • Rank —
Competitors: 279
- 62.4
educational
Opportunity: 58.0 • Difficulty: 42.1 • Rank —
Competitors: 96
- 60.5
age
Opportunity: 58.0 • Difficulty: 40.8 • Rank —
Competitors: 88
Unranked opportunities
range
Opportunity: 58.0 • Difficulty: 48.4 • Competitors: 261
medical
Opportunity: 58.0 • Difficulty: 38.6 • Competitors: 60
used
Opportunity: 58.0 • Difficulty: 52.9 • Competitors: 279
educational
Opportunity: 58.0 • Difficulty: 42.1 • Competitors: 96
age
Opportunity: 58.0 • Difficulty: 40.8 • Competitors: 88
High competition keywords
us
Total apps: 4,260 • Major competitors: 915
Latest rank: — • Difficulty: 57.5
hours
Total apps: 4,109 • Major competitors: 833
Latest rank: — • Difficulty: 57.3
including
Total apps: 3,880 • Major competitors: 926
Latest rank: — • Difficulty: 62.0
may
Total apps: 3,755 • Major competitors: 871
Latest rank: — • Difficulty: 61.6
day
Total apps: 3,361 • Major competitors: 731
Latest rank: — • Difficulty: 57.5
All tracked keywords
Includes opportunity, difficulty, rankings and competitor benchmarks
| Major Competitors | |||||||
|---|---|---|---|---|---|---|---|
| range | 58 | 100 | 48 | 71 1,314 competing apps Median installs: 239,262 Avg rating: 4.6 | — | — | 261 major competitor apps |
| particularly | 57 | 100 | 25 | 38 48 competing apps Median installs: 197,950 Avg rating: 4.7 | — | — | 6 major competitor apps |
| medical | 58 | 100 | 39 | 59 418 competing apps Median installs: 192,125 Avg rating: 4.7 | — | — | 60 major competitor apps |
| used | 58 | 100 | 53 | 72 1,494 competing apps Median installs: 237,800 Avg rating: 4.6 | — | — | 279 major competitor apps |
| educational | 58 | 100 | 42 | 62 571 competing apps Median installs: 207,750 Avg rating: 4.5 | — | — | 96 major competitor apps |
| treated | 56 | 100 | 21 | 30 21 competing apps Median installs: 275,875 Avg rating: 4.8 | — | — | 3 major competitor apps |
| age | 58 | 100 | 41 | 61 474 competing apps Median installs: 229,175 Avg rating: 4.5 | — | — | 88 major competitor apps |
| include | 58 | 100 | 45 | 64 693 competing apps Median installs: 243,825 Avg rating: 4.6 | — | — | 152 major competitor apps |
| life | 58 | 100 | 54 | 77 2,518 competing apps Median installs: 234,138 Avg rating: 4.6 | — | — | 503 major competitor apps |
| including | 58 | 100 | 62 | 81 3,880 competing apps Median installs: 285,400 Avg rating: 4.6 | — | — | 926 major competitor apps |
| motion | 57 | 100 | 40 | 54 256 competing apps Median installs: 270,825 Avg rating: 4.6 | — | — | 55 major competitor apps |
| products | 20 | 100 | 58 | 67 928 competing apps Median installs: 325,375 Avg rating: 4.7 | — | — | 263 major competitor apps |
| healthcare | 57 | 100 | 39 | 52 203 competing apps Median installs: 233,400 Avg rating: 4.6 | — | — | 36 major competitor apps |
| patients | 57 | 100 | 30 | 45 99 competing apps Median installs: 221,425 Avg rating: 4.6 | — | — | 21 major competitor apps |
| area | 58 | 100 | 44 | 61 510 competing apps Median installs: 271,450 Avg rating: 4.6 | — | — | 97 major competitor apps |
| tool | 58 | 100 | 47 | 69 1,134 competing apps Median installs: 210,275 Avg rating: 4.6 | — | — | 170 major competitor apps |
| improve | 58 | 100 | 50 | 74 1,897 competing apps Median installs: 240,375 Avg rating: 4.6 | — | — | 379 major competitor apps |
| professionals | 57 | 100 | 37 | 53 227 competing apps Median installs: 245,750 Avg rating: 4.7 | — | — | 42 major competitor apps |
| preparation | 57 | 100 | 25 | 38 46 competing apps Median installs: 168,075 Avg rating: 4.7 | — | — | 5 major competitor apps |
| joint | 57 | 100 | 29 | 36 40 competing apps Median installs: 233,062 Avg rating: 4.7 | — | — | 8 major competitor apps |
| important | 58 | 100 | 52 | 70 1,244 competing apps Median installs: 231,362 Avg rating: 4.6 | — | — | 248 major competitor apps |
| reduce | 58 | 100 | 46 | 59 421 competing apps Median installs: 239,800 Avg rating: 4.7 | — | — | 72 major competitor apps |
| training | 58 | 100 | 44 | 65 721 competing apps Median installs: 274,850 Avg rating: 4.7 | — | — | 157 major competitor apps |
| reported | 20 | 100 | 53 | 39 50 competing apps Median installs: 321,212 Avg rating: 4.6 | — | — | 16 major competitor apps |
| reports | 57 | 100 | 40 | 58 361 competing apps Median installs: 248,675 Avg rating: 4.6 | — | — | 69 major competitor apps |
App Description
This app is intended for training use by US healthcare professionals ONLY. Patients should seek a doctor’s advice before making any medical decisions.
OnabotulinumtoxinA Important Safety Information
OnabotulinumtoxinA Indications
Chronic Migraine
-OnabotulinumtoxinA is indicated for the prophylaxis of headaches in adult patients with Chronic Migraine (≥ 15 days per month with headache lasting 4 hours a day or longer).
Limitations of Use
-Safety and effectiveness have not been established for the prophylaxis of episodic migraine (14 headache days or fewer per month) in 7 placebo-controlled studies.
Spasticity
-OnabotulinumtoxinA is indicated for the treatment of spasticity in patients 2 years of age and older.
Limitations of Use
-OnabotulinumtoxinA has not been shown to improve upper extremity functional abilities or range of motion at a joint affected by a fixed contracture.
Cervical Dystonia
-OnabotulinumtoxinA is indicated for the treatment of adults with Cervical Dystonia to reduce the severity of abnormal head position and neck pain associated with Cervical Dystonia.
IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING
WARNING: DISTANT SPREAD OF TOXIN EFFECT
Postmarketing reports indicate that the effects of onabotulinumtoxinA and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses and in approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses.
Contraindications
-Hypersensitivity to any botulinum toxin preparation or to any of th